Rad N Bad: The Dosage Dilemma — Contingency, Evidence, and Ethics in ABA Treatment Intensity

Measurable Learning Objectives

Part 1: Empirical Literature & Dosage (1.0 Learning CEU)

Discriminate between treatment package characteristics and isolated dosage variables by evaluating early intensive behavioral intervention literature (Lovaas, 1987; Smith et al., 2000) alongside contemporary meta-analytic findings (Sandbank et al., 2024).

Contrast administrative treatment volume with behavioral treatment intensity, identifying at least four empirical parameters that govern effective behavioral dosage (e.g., active learning opportunity density, treatment fidelity, reinforcer effectiveness, and stimulus generalization).

Part 2: Ethics, Medical Necessity & Systems Contingencies (1.0 Ethics CEU)

Analyze organizational and funding contingencies under BACB Ethics Code 2.01 and 2.14, evaluating how fee-for-service reimbursement models can create competing contingencies that favor service maintenance over client titration and independence.

Formulate criteria-based titration and fading plans aligned with BACB Ethics Code 3.01, establishing objective clinical benchmarks to systematically fade direct therapy hours based on ongoing client progress and caregiver empowerment rather than arbitrary administrative tiers.

Relevant BACB Ethics Code Standards Addressed

Code 2.01: Providing Effective Treatment — Prioritizing evidence-based, scientifically validated interventions individualized to client and family needs over generalized organizational templates.

Code 2.14: Selecting, Designing, and Implementing Behavior-Change Interventions / Discontinuing Services — Systematically fading services and preparing clients and caregivers for discontinuation when clinical goals are met or lesser intervention suffices.

Code 3.01: Behavior-Analytic Assessment — Ensuring treatment recommendations, dosage determinations, and service scopes are derived strictly from comprehensive, functional assessment data rather than financial or scheduling expediency.

References & Foundational Literature

Behavior Analyst Certification Board. (2020). Ethics code for behavior analysts. Littleton, CO: Author.

Eikeseth, S., Smith, T., Jahr, E., & Eldevik, S. (2002). Intensive behavioral treatment at school for 4- to 7-year-old children with autism: A 1-year comparison controlled study. Behavior Modification, 26(1), 49–68.

Eldevik, S., Hastings, R. P., Hughes, J. C., Jahr, E., Eikeseth, S., & Cross, S. (2009). Meta-analysis of early intensive behavioral intervention for children with autism. Journal of Clinical Child and Adolescent Psychology, 38(3), 439–450.

Frazier, T. W., et al. (2024). Re-evaluating intervention dosage in autism spectrum disorder: Methodological considerations and clinical implications. JAMA Pediatrics, 178(5), 510–512.

Lovaas, O. I. (1987). Behavioral treatment and normal educational and intellectual functioning in young autistic children. Journal of Consulting and Clinical Psychology, 55(1), 3–9.

National Research Council. (2001). Educating Children with Autism. Washington, DC: National Academy Press.

Sandbank, M., Bottema-Beutel, K., Crowley, S., et al. (2024). Intervention amount and developmental outcomes in young children with autism: A meta-analysis. JAMA Pediatrics, 178(3), 260–269.

Smith, T., Groen, A. D., & Wynn, J. W. (2000). Randomized trial of intensive early intervention for children with pervasive developmental disorders. American Journal on Mental Retardation, 105(4), 269–285.